Unknown

Dataset Information

0

Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas.


ABSTRACT: Metabolic reprogramming is a common hallmark of cancer, but a large variability in tumor bioenergetics exists between patients. Using high-resolution respirometry on fresh biopsies of human lung adenocarcinoma, we identified 2 subgroups reflected in the histologically normal, paired, cancer-adjacent tissue: high (OX+) mitochondrial respiration and low (OX-) mitochondrial respiration. The OX+ tumors poorly incorporated [18F]fluorodeoxy-glucose and showed increased expression of the mitochondrial trifunctional fatty acid oxidation enzyme (MTP; HADHA) compared with the paired adjacent tissue. Genetic inhibition of MTP altered OX+ tumor growth in vivo. Trimetazidine, an approved drug inhibitor of MTP used in cardiology, also reduced tumor growth and induced disruption of the physical interaction between the MTP and respiratory chain complex I, leading to a cellular redox and energy crisis. MTP expression in tumors was assessed using histology scoring methods and varied in negative correlation with [18F]fluorodeoxy-glucose incorporation. These findings provide proof-of-concept data for preclinical, precision, bioenergetic medicine in oxidative lung carcinomas.

SUBMITTER: Amoedo ND 

PROVIDER: S-EPMC7773363 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas.

Amoedo Nivea Dias ND   Sarlak Saharnaz S   Obre Emilie E   Esteves Pauline P   Bégueret Hugues H   Kieffer Yann Y   Rousseau Benoît B   Dupis Alexis A   Izotte Julien J   Bellance Nadège N   Dard Laetitia L   Redonnet-Vernhet Isabelle I   Punzi Giuseppe G   Rodrigues Mariana Figueiredo MF   Dumon Elodie E   Mafhouf Walid W   Guyonnet-Dupérat Véronique V   Gales Lara L   Palama Tony T   Bellvert Floriant F   Dugot-Senan Nathalie N   Claverol Stéphane S   Baste Jean-Marc JM   Lacombe Didier D   Rezvani Hamid Reza HR   Pierri Ciro Leonardo CL   Mechta-Grigoriou Fatima F   Thumerel Matthieu M   Rossignol Rodrigue R  

The Journal of clinical investigation 20210101 1


Metabolic reprogramming is a common hallmark of cancer, but a large variability in tumor bioenergetics exists between patients. Using high-resolution respirometry on fresh biopsies of human lung adenocarcinoma, we identified 2 subgroups reflected in the histologically normal, paired, cancer-adjacent tissue: high (OX+) mitochondrial respiration and low (OX-) mitochondrial respiration. The OX+ tumors poorly incorporated [18F]fluorodeoxy-glucose and showed increased expression of the mitochondrial  ...[more]

Similar Datasets

| S-EPMC4306510 | biostudies-literature
| S-EPMC6166052 | biostudies-literature
| S-EPMC3506186 | biostudies-literature
| S-EPMC8995834 | biostudies-literature
| S-EPMC6142257 | biostudies-literature
| S-EPMC11385086 | biostudies-literature
| S-EPMC6122028 | biostudies-literature
| S-EPMC2801511 | biostudies-literature
| S-EPMC9542805 | biostudies-literature
| S-SCDT-10_1038-S44321-023-00013-X | biostudies-other